Feline asthma is a chronic inflammatory condition of the lower airways that affects an estimated 1 to 5 percent of all cats. It is characterized by reversible bronchoconstriction, airway inflammation, and excessive mucus production — pathological changes remarkably similar to human asthma. When a susceptible cat inhales an allergen or irritant, the immune system triggers an exaggerated inflammatory response in the bronchial walls, causing smooth muscle spasm, swelling of the airway lining, and accumulation of mucus that narrows the air passages.

The hallmark clinical sign is episodic coughing and wheezing. Owners often describe a characteristic posture: the cat crouches low with its neck extended and produces a dry, hacking cough that can be mistaken for trying to bring up a hairball. In severe episodes, cats may exhibit open-mouth breathing, cyanosis (bluish gums), and marked respiratory distress — a genuine emergency requiring immediate veterinary intervention.

Feline bronchitis is a closely related condition involving chronic inflammation of the bronchi without the classic reversible bronchoconstriction. In practice, the two conditions frequently overlap, and many clinicians use the umbrella term "chronic lower airway disease" when discussing both entities together.

Feline asthma is fundamentally an allergic and inflammatory condition. The underlying predisposition is likely genetic, but environmental triggers play a critical role in initiating and perpetuating airway inflammation.

Common Environmental Triggers

The Role of Eosinophilic Inflammation

The hallmark pathological finding in feline asthma is eosinophilic infiltration of the bronchial walls. Eosinophils are white blood cells associated with allergic responses. When activated in the airways, they release inflammatory mediators that damage the epithelial lining, stimulate mucus-producing cells, and promote smooth muscle hypertrophy — all changes that progressively worsen airway function over time.

This is why long-term anti-inflammatory therapy is the cornerstone of treatment. Without ongoing inflammation control, repeated episodes lead to airway remodeling — permanent structural changes that make the airways increasingly resistant to treatment.

There is no single definitive test for feline asthma. Diagnosis is based on a combination of clinical signs, imaging findings, and exclusion of other causes of coughing and respiratory distress in cats.

Thoracic Radiography

Chest X-rays are the first-line diagnostic tool. Classic radiographic findings in asthmatic cats include a diffuse bronchial pattern (thickened bronchial walls visible as "donuts" on end-on views and "tramlines" on longitudinal views), hyperinflation of the lungs due to air trapping, and in some cases lung lobe collapse from mucus plugging. However, radiographs can appear normal in mildly affected cats, so a normal X-ray does not rule out the disease.

Bronchoalveolar Lavage (BAL)

BAL involves instilling sterile saline into the airways through an endotracheal tube under general anesthesia, then retrieving the fluid for cytological analysis. Findings of eosinophilic inflammation (greater than 17 percent eosinophils) strongly support a diagnosis of asthma. BAL also allows culture to rule out bacterial or Mycoplasma infections that can mimic or complicate asthma.

Ruling Out Differential Diagnoses

Advanced Imaging

CT scanning provides superior detail of the airways and lung parenchyma compared to radiography. It is increasingly used in referral settings to evaluate the extent of airway remodeling and to identify subtle changes not visible on standard X-rays.

The goals of feline asthma therapy are to reduce airway inflammation, relieve bronchoconstriction during acute episodes, and minimize exposure to environmental triggers. Most cats require lifelong management.

Corticosteroids — The Anti-Inflammatory Foundation

Corticosteroids are the mainstay of asthma treatment because they directly target the underlying eosinophilic inflammation. They can be administered in three forms:

Oral prednisolone is commonly used for initial stabilization and in cats whose owners cannot administer inhaled medication. Typical starting doses are 1–2 mg/kg once daily, gradually tapered to the lowest effective dose. Long-term systemic steroid use carries risks including diabetes mellitus, urinary tract infections, and immunosuppression.

Inhaled corticosteroids — specifically fluticasone propionate (Flovent) delivered through a feline-specific spacer chamber such as the AeroKat — represent the preferred long-term approach. Inhaled steroids deliver medication directly to the airways at much lower systemic doses, dramatically reducing the risk of side effects. Most cats can be trained to accept the spacer with patient, gradual conditioning.

Injectable long-acting steroids (methylprednisolone acetate / Depo-Medrol) provide convenient dosing but carry the highest risk of systemic side effects and are generally reserved for cats that cannot receive oral or inhaled medication.

Bronchodilators — Acute Relief

Bronchodilators relax the smooth muscle surrounding the airways and provide rapid relief during acute bronchoconstriction. Albuterol (salbutamol) delivered via metered-dose inhaler through the AeroKat spacer is the preferred rescue medication. Terbutaline can be given as a subcutaneous injection in emergency settings for cats in severe respiratory distress.

Bronchodilators alone do not address the underlying inflammation and should never be used as sole therapy — doing so can actually worsen long-term outcomes by masking disease progression.

Emergency Management

Cats presenting in acute respiratory distress require oxygen supplementation, injectable bronchodilators (terbutaline), and fast-acting corticosteroids. Minimal handling is critical, as stress can worsen respiratory compromise in these fragile patients.

Successful long-term management of feline asthma requires a combination of medical therapy and environmental control. With consistent treatment, most asthmatic cats can live comfortable, active lives with normal or near-normal life expectancy.

Environmental Modifications

Monitoring at Home

Owners should learn to monitor their cat's resting respiratory rate (RRR) — the number of breaths per minute while sleeping. A normal cat takes 15–30 breaths per minute at rest. A persistent resting rate above 40 breaths per minute suggests worsening disease and warrants veterinary evaluation. Smartphone apps are available to help track RRR over time.

Keeping a log of coughing episodes — frequency, duration, time of day, and potential triggers — helps veterinarians adjust therapy more precisely.

Prognosis

The majority of cats with well-managed asthma have an excellent long-term prognosis. Cats that develop severe airway remodeling or those with frequent, poorly controlled crises may have a more guarded outlook. The transition from oral steroids to inhaled therapy is strongly encouraged whenever possible to minimize cumulative steroid side effects over a cat's lifetime. Regular veterinary rechecks — typically every 6–12 months for stable patients — allow treatment adjustments before clinical deterioration occurs.